The data of our study showed that high RBP2 expression is common in stage I NSCLC tissues and is significantly associated with tumor size, high HIF-1α expression, high VEGF expression and a poor prognosis, suggesting that the RBP2 protein is involved in the aggressive progression of NSCLC. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.